Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: Advancing precision oncology
Abstract Prostate cancer (PCa) ranks among the most prevalent cancers in men worldwide. Biochemical recurrence (BCR) presents a major clinical challenge in PCa management, with significant prognostic heterogeneity observed among patients post-recurrence. This study aimed to develop machine learning...
Saved in:
| Main Authors: | Yaxuan Wang, Haixia Zhu, Jianlan Ren, Minghua Ren |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | npj Digital Medicine |
| Online Access: | https://doi.org/10.1038/s41746-025-01930-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic systematic review and meta-analysis of machine learning in predicting biochemical recurrence of prostate cancer
by: Chenyang Ling, et al.
Published: (2025-08-01) -
Advances in Application of Federated Machine Learning for Oncology and Cancer Diagnosis
by: Mohammad Nasajpour, et al.
Published: (2025-06-01) -
Development of a deep learning system for predicting biochemical recurrence in prostate cancer
by: Lu Cao, et al.
Published: (2025-02-01) -
Racial Disparities in Prostate Cancer Incidence, Biochemical Recurrence, and Mortality
by: Cathryn H. Bock, et al.
Published: (2011-01-01) -
The role of advanced diagnostics on precision medicine in hemato oncology
by: Befikad Mandefro, et al.
Published: (2025-08-01)